The UW Medical Student Addiction Research (MedStAR) Program to Address Substance Use and Disorders in Urban and Rural Communities in Five Western States
华盛顿大学医学院学生成瘾研究 (MedStAR) 计划旨在解决西部五个州城乡社区的药物使用和疾病问题
基本信息
- 批准号:10159236
- 负责人:
- 金额:$ 37.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAlaskaAmericanAreaAttentionAwarenessBehaviorBehavioral ResearchBeliefBiomedical ResearchCareer ChoiceCaringClinicalClinical ResearchCommunity PhysicianComplementComplexDiscipline of obstetricsDrug AddictionEducationEducation ProjectsEducational ActivitiesEmergency MedicineEnsureEnvironmentEvidence based practiceEvidence based treatmentFacultyFamily PracticeFellowshipFundingFutureGenerationsGoalsGynecologyHIV/HCVHealthIdahoIndividualInternal MedicineKnowledgeLearningLife ExpectancyMedicalMedical EducationMedical StudentsMedicineMentorsMontanaNCI Scholars ProgramNational Institute of Drug AbuseOperative Surgical ProceduresOutcomePatient CarePatientsPediatricsPersonsPharmaceutical PreparationsPhysiciansPopulationPsychiatryPublicationsReadinessResearchResearch MethodologyResearch PersonnelResearch Project GrantsResearch TrainingRuralRural CommunityScientistStigmatizationStudentsSubstance AddictionSubstance Use DisorderSubstance abuse problemTalentsTargeted ResearchTimeTrainingUniversitiesUrban CommunityWashingtonWyomingaddictioncareerclinical careclinically relevantcollegeearly experienceeducation researchevidence baseexperiencefallshands on researchimprovedinterestlecturesmedical schoolsmedical specialtiesmeetingsmodel developmentmortalitynext generationopioid epidemicopioid use disorderpostersprogramsrural areasubstance usesymposium
项目摘要
ABSTRACT/PROJECT SUMMARY
Substance use disorders (SUDs) affect millions of Americans and have enormous impact on overall health and
mortality. In the past decade, opioid use disorders have emerged as a major health crisis throughout urban and
rural communities. The dissemination of knowledge and implementation of evidence-based practices remains
a challenge for achieving improved SUD-related health outcomes in the real world, particularly in rural areas.
Physicians are on the frontlines of identifying and treating patients with SUD, and are thus uniquely situated to
implement evidence-based care and identify areas for further research, yet there is a scarcity of addiction
medicine trained clinicians and physician-scientists who can advance the field. The University of Washington
(UW) School of Medicine is uniquely poised to develop an addictions research education program for medical
students. The medical school provides training to students across a 5-state region covering 25% of the nation's
landmass: Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI). We propose the following specific
aims: Aim #1 is to develop the Medical Student Addiction Research (MedStAR) Program within the UW
School of Medicine to provide opportunities for mentored research and training; Aim #2 is to encourage
medical students to consider careers in Addiction Medicine and research by establishing longitudinal
mentoring relationships and collaborative networks. We will train 6–8 medical students annually during a
9-week block that is dedicated to research between their 1st and 2nd years. To carry out their mentored
research project they will be paired with a primary research mentor, an Addiction Medicine trained clinical
mentor, and a research methods “coach.” Students in the program will also learn about Addiction Medicine
careers, including the option for Addiction Medicine fellowships, during their 9-week block. In addition, mentors
(research and clinical) will provide longitudinal mentoring throughout medical school through quarterly
meetings. A meeting of MedStAR students from all classes will be organized annually to facilitate the creation
of a network of students with common interests, and students will attend the annual College for Drug
Dependence conference where they can network with fellows and faculty from another R25 program (the
“Research in Addiction Medicine Scholars” program). Through the creation of the MedStAR program, we will
create a cadre of medical students who are poised to become the next generation of clinicians and scientists to
implement and disseminate evidence-based care for patients with SUDs.
摘要/项目摘要
药物使用障碍(SUD)会影响数百万美国人,并对整体健康和
死亡。在过去的十年中,阿片类药物使用障碍已成为整个城市和
农村社区。知识的传播和基于循证实践的实施仍然存在
在现实世界中,尤其是在农村地区,取得改善与SUD相关的健康成果的挑战。
医生处于识别和治疗SUD患者的前线,因此独特地位于
实施基于证据的护理并确定进一步研究的领域,但成瘾很少
医学培训的临床医生和身体科学家可以推进该领域。华盛顿大学
(UW)医学院被毒死,以开发医学成瘾研究教育计划
学生。医学院为五个州地区的学生提供培训,占全国25%的培训
陆地:华盛顿,怀俄明州,阿拉斯加,蒙大拿州和爱达荷州(第二次世界大战)。我们提出以下特定
目的:目标#1是在UW中制定医学学生成瘾研究(MEDSTAR)计划
医学院为修订研究和培训提供机会;目标2是鼓励
医学生通过建立纵向来考虑成瘾医学和研究的职业
指导关系和协作网络。我们每年将在
为期9周的街区,致力于他们的第一年至第二年。进行他们的指导
研究项目他们将与基本研究,成瘾医学培训的临床配对
导师和一种研究方法“教练”。该计划中的学生还将了解成瘾医学
职业,包括成瘾医学奖学金的选择,他们的9周街区。另外,导师
(研究和临床)将通过季度提供整个医学院的纵向心理
会议。每年将举办来自所有课程的Medstar学生的会议,以促进创作
有共同利益的学生网络,学生将参加年度毒品学院
依赖性会议他们可以在此处与其他R25计划与研究员和教师建立联系(
“成瘾医学研究学者”计划。通过创建Medstar计划,我们将
创建一批被毒死的医学学生,他们成为下一代临床医生和科学家
为SUD患者实施并传播基于证据的护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Judith Tsui其他文献
Judith Tsui的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Judith Tsui', 18)}}的其他基金
Patient Navigator plus Remote mHealth Adherence Support with Incentives: Understanding Criminal Justice Effects
患者导航器加上带有激励措施的远程 mHealth 依从性支持:了解刑事司法影响
- 批准号:
10840579 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
Patient Navigator plus Remote mHealth Adherence Support with Incentives to Improve Linkage and Retention among Hospitalized Patients with Opioid and Methamphetamine Use Who Initiate Buprenorphine
患者导航器加上远程 mHealth 依从性支持和激励措施,可改善开始使用丁丙诺啡的阿片类药物和甲基苯丙胺住院患者的联系和保留
- 批准号:
10588501 - 财政年份:2022
- 资助金额:
$ 37.69万 - 项目类别:
The UW Medical Student Addiction Research (MedStAR) Program to Address Substance Use and Disorders in Urban and Rural Communities in Five Western States
华盛顿大学医学院学生成瘾研究 (MedStAR) 计划旨在解决西部五个州城乡社区的药物使用和疾病问题
- 批准号:
10385746 - 财政年份:2020
- 资助金额:
$ 37.69万 - 项目类别:
The UW Medical Student Addiction Research (MedStAR) Program to Address Substance Use and Disorders in Urban and Rural Communities in Five Western States
华盛顿大学医学院学生成瘾研究 (MedStAR) 计划旨在解决西部五个州城乡社区的药物使用和疾病问题
- 批准号:
9980616 - 财政年份:2020
- 资助金额:
$ 37.69万 - 项目类别:
The UW Medical Student Addiction Research (MedStAR) Program to Address Substance Use and Disorders in Urban and Rural Communities in Five Western States
华盛顿大学医学院学生成瘾研究 (MedStAR) 计划旨在解决西部五个州城乡社区的药物使用和疾病问题
- 批准号:
10600013 - 财政年份:2020
- 资助金额:
$ 37.69万 - 项目类别:
Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject Drugs
社区药房模式试点研究,以扩大注射吸毒者获得治疗和预防丙型肝炎、阿片类药物使用障碍、药物过量和艾滋病毒的药物的机会
- 批准号:
9978028 - 财政年份:2019
- 资助金额:
$ 37.69万 - 项目类别:
Pilot Study of a Community-Pharmacy Model to Expand Access to Medications to Treat and Prevent Hepatitis C, Opioid Use Disorders, Overdose and HIV Among Persons Who Inject Drugs
社区药房模式试点研究,以扩大注射吸毒者获得治疗和预防丙型肝炎、阿片类药物使用障碍、药物过量和艾滋病毒的药物的机会
- 批准号:
10197864 - 财政年份:2019
- 资助金额:
$ 37.69万 - 项目类别:
HCV and Pain in Substance Users With and Without HIV
丙型肝炎病毒(HCV)与吸毒者和未感染艾滋病毒的人的疼痛
- 批准号:
8259449 - 财政年份:2010
- 资助金额:
$ 37.69万 - 项目类别:
HCV and Pain in Substance Users With and Without HIV
丙型肝炎病毒(HCV)与吸毒者和未感染艾滋病毒的人的疼痛
- 批准号:
8080439 - 财政年份:2010
- 资助金额:
$ 37.69万 - 项目类别:
HCV and Pain in Substance Users With and Without HIV
丙型肝炎病毒(HCV)与吸毒者和未感染艾滋病毒的人的疼痛
- 批准号:
7930147 - 财政年份:2010
- 资助金额:
$ 37.69万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society
下一代本土遗传学、伦理学和社会研究人员的培训和提升计划
- 批准号:
10841760 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients with Chronic Pain
适应和实施护理管理模式来护理农村慢性疼痛患者
- 批准号:
10741606 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
Addressing Structural Disparities in Autism Spectrum Disorder through Analysis of Secondary Data (ASD3)
通过二手数据分析解决自闭症谱系障碍的结构性差异 (ASD3)
- 批准号:
10732506 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
Visinin-like protein-1 modulation of nicotinic receptors
Visinin 样蛋白-1 烟碱受体的调节
- 批准号:
10712709 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别: